Notably, this clinical validation aligns with the previously discussed involvement of ARL2 in mitochondrial function and neuroinflammatory pathways, providing a mechanistic basis for its upregulation under conditions of hypoxic and inflammatory stress, such as those characterizing OSA and stroke comorbidity. The gene discussed is ARL2; the disease is stroke disorder.